Vanguard Fiduciary Trust
NAGE

Vanguard Fiduciary Trust’s Niagen Bioscience NAGE Stock Holding History

Vanguard Fiduciary Trust’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Buy
400,253
+25,899
+7% +$105K ﹤0.01% 2920
2026
Q1 		$1.65M Buy
+374,354
New +$2.02M ﹤0.01% 2669

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Fiduciary Trust's NAGE Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Niagen Bioscience (NAGE) stake by 6.9% in Q2 2026, buying an estimated $105K and bringing the position to 400,253 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2920.

Vanguard Fiduciary Trust first reported a position in NAGE in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.65M in Q1 2026. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Vanguard Fiduciary Trust held 400,253 shares of Niagen Bioscience worth $1.28M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 25,899 Niagen Bioscience shares in Q2 2026, an estimated $105K.
  • Niagen Bioscience made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2920 holding.
  • Vanguard Fiduciary Trust first reported a position in Niagen Bioscience in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Niagen Bioscience position peaked at $1.65M in Q1 2026.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.